Skin cancer — all decisions

The Board remands the claim for service connection for basal cell and squamous cell skin cancer to obtain a VA opinion and examination, as required by the PACT Act due to the Veteran's participation in a toxic exposure risk activity during service.

The Board remands the claims for service connection for skin cancer, type II diabetes, hypertension, ulcerative colitis with polyps, stomach ulcers, Barrett's esophagus, and fatty liver to correct duty-to-assist errors.

The Board denied an initial compensable rating for partial prostatectomy scars and remanded the claims for service connection, increased rating for MDD, and TDIU due to duty to assist errors.

The Board denied the Veteran's claim for service connection for skin cancer, finding no evidence of a causal relationship between the Veteran's current condition and his military service.

The Board denied service connection for a skin disorder, as the evidence did not support a finding that the Veteran's diagnosed skin disorders were incurred in or caused by his active service.

The Board denied the veteran's claims for service connection for COPD, melanoma basal squamous, nasopharynx cysts, submucosal stomach tumors or lesions, and myelofibrosis grade 1 as no new and relevant evidence was submitted to support these claims.

The veteran's appeals for service connection and increased rating were dismissed due to untimely filings.

The appeal for service connection for tinnitus, melanoma to the left lower eye lid, and skin cancer on the back was dismissed. The appeal for asthma was granted in part, as a Higher-Level Review (HLR) request was timely filed. Other appeals were denied.

The Board granted service connection for thyroid cancer and denied an initial rating in excess of 50 percent for PTSD, while remanding claims for service connection for erectile dysfunction, squamous cell carcinoma and malignant melanoma, and TDIU.

The Board granted service connection for Non Proliferative Diabetic Retinopathy with macular edema secondary to diabetes mellitus and denied the claims for a right shoulder condition, right upper extremity neuropathy, and skin cancer.

The Board granted service connection for several disabilities, including left thumb, left wrist, right hip, back, and sciatic nerve conditions, but denied service connection for diabetes mellitus.

The Board denied service connection for squamous cell skin cancer, chronic fatigue syndrome, tuberculosis, hematuria, hypercholesterolemia, and vitamin deficiency. However, the Board granted service connection for a right knee disorder, left knee disorder, and plantar fasciitis.

The appeal for service connection for skin cancer was dismissed as the Veteran withdrew his claim during a Board hearing.

The Board remands the claim for service connection for skin cancer to obtain an addendum medical opinion, as the September 2024 VA examination is deemed inadequate.

The Board remands the claims for service connection for a heart condition and skin cancer with residual scars to correct pre-decisional duty to assist errors.

The Board denied service connection for bilateral hearing loss and remanded the claims for service connection for bilateral knee medial meniscus repair, upper back strain, and malignant melanoma.

The Board remands the issue of entitlement to service connection for skin cancer, to include as due to radiation exposure, for further development in accordance with 38 C.F.R. § 3.311 and the provisions of the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 (PACT Act).

The Board denied service connection for skin cancer and skin rashes as the evidence did not support a finding that these conditions were incurred during active service or are otherwise related to an in-service injury or disease.

The Board remands the Veteran's claims for service connection for small bowel cancer, lung cancer, prostate cancer, and skin cancer to correct a pre-decisional duty-to-assist error related to VA's statutory duties under the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 (PACT Act).

The Board remands the claim for service connection for malignant melanoma to correct a pre-decisional duty to assist error, specifically to obtain a medical opinion that considers all in-service toxic exposures.